Senior Director, Drug Development Services (Cardiometabolic)
ICON plc - 2 Locations
Posted Nov 3, 2026
Benefits
- Parental leave
- Not verified
- Non-birth-parent leave
- Not verified
- Family-building benefits
-
- Fertility benefits: Not verified
- Adoption assistance: Not verified
- Surrogacy assistance: Not verified
- Mental health support
- Not verified
- Relocation assistance
- Not verified
- Childcare support
- Not verified
- Learning budget
- Not verified
- Verification
- Not verified
- Salary
- $196K-$245K From the posting source checked Nov 16, 2026
Was this benefit information wrong? Tell us.
Role
Schedule
- Shift type
- Not verified
- Weekend work
- Not verified
Application
- Cover letter
- Not verified
- Assessment
- Not verified
- Deadline
- Not stated
Where they hire
State eligibility is not yet verified.
About this role
Senior Director, Drug Development Services (Cardiometabolic) 2 Locations Sr Director Therapeutic Area (Hepatology)- US- Remote ICON is a global healthcare intelligence and clinical research organisation united by a mission to bring new medicines and treatments to patients faster. As a values-driven organisation, integrity, collaboration, agility, and inclusion are at the heart of how we work and interact with each other, customers, patients and suppliers. Senior Director, Drug Development & Consulting - Cardiometabolic At ICON plc, we are driven by commitment to People, Clients, and Performance. We are seeking a strategic Cardiometabolic expert to join our Drug Development & Consulting team in a highly visible, client-facing role. This position offers the opportunity to act as a trusted advisor to senior stakeholders across the industry, including CEOs, CMOs, and other Cardiometabolic Therapeutic Area Heads. You will deliver bespoke, asset-centric solutions while shaping Cardiometabolic drug development strategies across the full lifecycle. The Role This is a consultative and advisory role where you will serve as a key scientific partner to both external clients and internal teams. Often acting as the first technical point of contact, you will play a critical role in pre-sales activities, proposal strategy, and long-term partnership development within Cardiometabolic. Key Responsibilities Lead strategic Cardiometabolic drug development design, delivering tailored, asset-focused solutions across liver diseases including MASLD/MASH, alcohol-associated liver disease (ALD), cirrhosis, viral hepatitis, and other chronic and rare liver conditions like PBC, PSC, PFIC Own end-to-end protocol development, including design, scientific review, and evaluation for Cardiometabolic clinical trials across Phases
Read the full description at icon.wd3.myworkdayjobs.com. FewerJobs shows a preview and links to the original posting.
Apply link verified; last checked Nov 20, 2026.
What verified means
Verified means a displayed claim has field-level provenance to a source FewerJobs pulled: a government or employer source, or the original job posting. Posting-sourced facts are employer-stated and are labeled separately from government records.
Related jobs
Senior Director, Drug Development Services - CGT
ICON plc - 7 Locations
Senior Director, Pharmacometrics
Amylyx Pharmaceuticals Inc - Cambridge, MA
Senior Medical Director, Clinical Development, Obesity
Regeneron Pharmaceuticals - 3 Locations
Senior Director, Clinical Development Medical Director- Obesity and Related Conditions
Amgen - United States - Remote